Related Experiment Video
Updated: Jun 5, 2026

Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point
Published on: June 28, 2024
A rare case of malignant pediatric ectomesenchymoma arising from the falx cerebri
Dana L Altenburger1, Aaron S Wagner, Don E Eslin
1Department of Pathology, Orlando Health, 83 West Columbia Street, Orlando, FL 32806, USA.
Abstract:
Malignant ectomesenchymoma is a rare tumor arising from mature ganglion cells with immature myogenous elements, with only 4 pediatric intracranial cases having been previously reported. The authors report a rare case of intracranial malignant ectomesenchymoma originating from the falx cerebri in a 10-year-old boy. The patient presented with a 2-week history of headache, nausea, and blurry vision, with mild lateral gaze diplopia. A CT scan revealed a solitary 7.2 × 3.8-cm dural-based mass that extended along the falx. No metastatic disease was identified, and the lesion was grossly resected without complication. Pathological investigation identified single and small groups of cells in a myxoid background, with polygonal or spindle-shaped cells containing eccentric nuclei and prominent nucleoli. Immunohistochemical staining of some cells was positive for smooth-muscle actin, CD99, and vimentin, whereas other cells (often process forming) were positive for S100 protein, synaptophysin, and neurofilament protein. Staining was negative for CD138, CD45, α-fetoprotein, CK AE1/3, glial fibrillary acidic protein, CK7, CK20, CD31, CD34, myoD, and desmin. Normal immunopositivity was seen for INI-1. The Ki 67 immunostaining had < 25% reactivity. The patient was treated with a sarcoma-based chemotherapy regimen and radiation to the craniospinal axis, and was found to be without recurrence or metastatic disease at 20 months.
Insights
This report details a rare intracranial malignant ectomesenchymoma in a pediatric patient. Complete surgical resection and adjuvant therapy led to a favorable outcome with no recurrence at 20 months.
Area of Science:
- Pediatric Oncology
- Neuro-oncology
- Rare Tumors
Background:
- Malignant ectomesenchymoma is an exceptionally rare tumor with limited reported pediatric intracranial cases.
- This tumor type originates from mature ganglion cells and immature myogenous elements.
Purpose of the Study:
- To report a rare case of intracranial malignant ectomesenchymoma in a pediatric patient.
- To describe the clinical presentation, diagnostic findings, and treatment of this rare dural-based tumor.
Main Methods:
- Case presentation of a 10-year-old boy with an intracranial mass.
- Diagnostic imaging (CT scan) and extensive immunohistochemical analysis.
- Surgical resection followed by sarcoma-based chemotherapy and craniospinal axis radiation.
Main Results:
- A 7.2 × 3.8-cm dural-based mass originating from the falx cerebri was identified.
- Immunohistochemistry revealed biphenotypic differentiation with markers for smooth muscle, neural, and mesenchymal elements.
- The patient achieved complete resection and showed no evidence of recurrence or metastasis at 20 months post-treatment.
Conclusions:
- Intracranial malignant ectomesenchymoma is a rare but treatable pediatric tumor.
- Multimodal treatment including surgery, chemotherapy, and radiation can lead to favorable outcomes.
- This case highlights the importance of comprehensive pathological and immunohistochemical evaluation for accurate diagnosis and management.
